Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 6601 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2014 | Standard Therapy | Germany | 55 |
| 6602 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2014 | Standard Therapy | Germany | 57 |
| 6603 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2014 | Standard Therapy | Germany | 56 |
| 6604 | Apheresis | Allogeneic | Myeloproliferative Syndrome | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 6605 | Apheresis | Autologous | Neuroblastoma | Hematology | 2014 | Standard Therapy | Germany | 7 |
| 6606 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 6607 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 43 |
| 6608 | Apheresis | Autologous | Post-Transplant Lymphoproliferative Disorder | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 6609 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 69 |
| 6610 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 64 |
| 6611 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 42 |
| 6612 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 51 |
| 6613 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 56 |
| 6614 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 75 |
| 6615 | Apheresis | Autologous | Secondary Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 59 |
| 6616 | Apheresis | Autologous | T-Cell Lymphoblastic Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 54 |
| 6617 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 46 |
| 6618 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 48 |
| 6619 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 43 |
| 6620 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma Relapse | Hematology | 2014 | Standard Therapy | Germany | 56 |
| 6621 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2013 | Experimental Therapy | Poland | 18,9 |
| 6622 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2013 | Experimental Therapy | Poland | 2,11 |
| 6623 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2013 | Experimental Therapy | Poland | 3,5 |
| 6624 | Cord Tissue | Allogeneic – Unrelated | Acute Myeloid Leukemia | Hematology | 2013 | Experimental Therapy | Poland | 3,5 |
| 6625 | Cord Tissue | Allogeneic – Unrelated | Chronic Graft Versus Host Disease | Hematology | 2013 | Experimental Therapy | Poland | 18,8 |
| 6626 | Cord Tissue | Allogeneic – Unrelated | Chronic Graft Versus Host Disease | Hematology | 2013 | Experimental Therapy | Poland | 17,5 |
| 6627 | Cord Blood | Allogeneic – Related | Acute Lymphoblastic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 8 |
| 6628 | Cord Blood | Allogeneic – Related | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Poland | 3 |
| 6629 | Cord Blood | Allogeneic – Related | Aplastic Anemia | Hematology | 2013 | Standard Therapy | Poland | 3 |
| 6630 | Cord Blood | Allogeneic – Related | Leukemia | Hematology | 2013 | Standard Therapy | Turkey | 7 |
| 6631 | Cord Blood | Allogeneic – Related | Thalassemia | Hematology | 2013 | Standard Therapy | UK | 5 |
| 6632 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2013 | Standard Therapy | Turkey | 7,12 |
| 6633 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2013 | Standard Therapy | Turkey | 3 |
| 6634 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2013 | Standard Therapy | Turkey | ? |
| 6635 | Cord Blood | Allogeneic – Related | Wiskott-Aldrich Syndrome | Hematology | 2013 | Standard Therapy | Germany | 3 |
| 6636 | Cord Blood | Allogeneic – Related | X-Linked Lymphoproliferative Syndrome | Hematology | 2013 | Standard Therapy | Poland | 10 months |
| 6637 | Bone Marrow Family | Allogeneic | Follicular Lymphoma + Non-Hodgkin-Hodgkin | Hematology | 2013 | Standard Therapy | Germany | 38 |
| 6638 | Bone Marrow Family | Allogeneic | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 58 |
| 6639 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2013 | Standard Therapy | Germany | 73 |
| 6640 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2013 | Standard Therapy | Germany | 71 |
| 6641 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 44 |
| 6642 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 17 |
| 6643 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 55 |
| 6644 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 51 |
| 6645 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 21 |
| 6646 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 18 |
| 6647 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 59 |
| 6648 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 55 |
| 6649 | Apheresis | Allogeneic | Acute Myeloid Leukemia – Relapse | Hematology | 2013 | Standard Therapy | Germany | 62 |
| 6650 | Apheresis | Autologous | Angioimmunoblastic Lymphadenopathy With Dysproteinemia – Relapse | Hematology | 2013 | Standard Therapy | Germany | 51 |
| 6651 | Apheresis | Autologous | Angioimmunoblastic Lymphadenopathy With Dysproteinemia – Relapse | Hematology | 2013 | Standard Therapy | Germany | 54 |
| 6652 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 55 |
| 6653 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 62 |
| 6654 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma – Relapse | Hematology | 2013 | Standard Therapy | Germany | 52 |
| 6655 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma – Relapse | Hematology | 2013 | Standard Therapy | Germany | 32 |
| 6656 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma – Relapse | Hematology | 2013 | Standard Therapy | Germany | 51 |
| 6657 | Apheresis | Autologous | Burkitt Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 49 |
| 6658 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 48 |
| 6659 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 48 |
| 6660 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 64 |
| 6661 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 61 |
| 6662 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 54 |
| 6663 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2013 | Standard Therapy | Germany | 62 |
| 6664 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2013 | Standard Therapy | Germany | 54 |
| 6665 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 39 |
| 6666 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 43 |
| 6667 | Apheresis | Allogeneic | Hypoplastic Myelodysplastic Syndrome | Hematology | 2013 | Standard Therapy | Germany | 32 |
| 6668 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 47 |
| 6669 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2013 | Standard Therapy | Germany | 50 |
| 6670 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2013 | Standard Therapy | Germany | 62 |
| 6671 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 70 |
| 6672 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 52 |
| 6673 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 48 |
| 6674 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 65 |
| 6675 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 62 |
| 6676 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 73 |
| 6677 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 55 |
| 6678 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 53 |
| 6679 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 56 |
| 6680 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 61 |
| 6681 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 54 |
| 6682 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 60 |
| 6683 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 64 |
| 6684 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 66 |
| 6685 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 59 |
| 6686 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 65 |
| 6687 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 59 |
| 6688 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 65 |
| 6689 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 45 |
| 6690 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 50 |
| 6691 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 78 |
| 6692 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 46 |
| 6693 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 53 |
| 6694 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 65 |
| 6695 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 61 |
| 6696 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 40 |
| 6697 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 58 |
| 6698 | Apheresis | Allogeneic | Mycosis Fungoides | Hematology | 2013 | Standard Therapy | Germany | 62 |
| 6699 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2013 | Standard Therapy | Germany | 62 |
| 6700 | Apheresis | Autologous | Neuroblastoma | Hematology | 2013 | Standard Therapy | Germany | 3 |